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It remains unclear whether dietary salt
intake over years (not just at baseline)
inﬂuences hard outcomes. We have
previously demonstrated an increased
risk of mortality in patients with type 2
diabetes (T2D) and low baseline 24-h
urinary sodium excretion (24hUNa) (1).
Based on the same cohort of patients,
the aim of the current study was to
examine the relationship among serial
measurements of 24hUNa, estimated
glomerular ﬁltration rate (eGFR), and all-
cause mortality, adjusting for covariates
associated with 24hUNa and eGFR.
This was a prospective cohort study of
patients with T2D attending a single
tertiary hospital diabetes clinic, initiated
in mid-2000 with follow-up completed
in 2010 (1). Serial 24hUNa (mmol/24 h)
and eGFR (mL/min/1.73 m2)
measurements were performed at
regular intervals. The impact of 24hUNa
and eGFR over time on all-cause
mortality was determined by a joint
model of longitudinal (linear-mixed
model) and time-to-event (Weibull
parametric survival model) data.
Follow-up 24hUNa and eGFR data from
588 patients were used in the current
analysis. There were 152 deaths (26%)
after a median follow-up of 9 years.
Signiﬁcant predictors of eGFR in the
linear-mixed model were baseline eGFR
and BMI, age, sex, follow-up time
(years), and 24hUNa and albumin
excretion rate over time. Survival model
predictors were sex, 24hUNa, and eGFR
over time; baseline eGFR; diastolic
blood pressure; presence of congestive
heart failure and/or atrial ﬁbrillation;
and duration of diabetes.
The relationship between all-cause
mortality and 24hUNa (adjusted for
covariates) is demonstrated in Fig. 1,
where an increase in all-cause mortality
was evident in those with lower 24hUNa.
Predicted survival at 9.5 years ranged
from 94% (24hUNa 5 264 mmol/24 h;
90th percentile) to 77.5% (24hUNa 5
96 mmol/24 h; 10th percentile).
Low24hUNawas associatedwith increased
all-causemortality, allowing for changes in
24hUNa and eGFR over time, consistent
with the original study ﬁndings (1).
Limitations are recognized.
Observational data presented here are
restricted to patients with long-standing
T2D and our analysis is hypothesis-
generating rather than identifying a
direct causal relationship. Furthermore,
observational studies may be subject to
confounding.
The strengths are the use of multiple
24hUNa measurements to estimate
dietary salt intake over time in each
individual and the use of a joint model for
statistical analysis (2,3). Joint modeling
has not been previously used to predict
mortality in cohort studies of dietary salt
intake and has the advantage that over
time repeated measurements can reduce
measurement error and overcome the
effect of treatment of covariates (4).
Low 24hUNa excretion over time was
associated with increased mortality in
people with T2D. The study ﬁndings are in
line with the Institute of Medicine report
(5) no longer recommending lowering
sodium intake to#65 mmol/24 h in
patients with diabetes. These ﬁndings call
for research on the effects of habitual
low salt intake on markers of renin-
angiotensin-aldosterone system activity,
endothelial function, and sympathetic
nervous system activity in people with
diabetes. Studies, now in progress, should
help to resolve the question of whether
low dietary salt intake is a pathogenetic
factor, as opposed to a marker, for
cardiovascular or renal events in diabetes.
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Figure 1—All-cause mortality across percentiles of 24hUNa (mmol/24 h), averaged over covariate effect. All-cause mortality: effect of percentiles of
24hUNa (mmol/24 h), taking into account longitudinal measurements of 24hUNa and eGFR throughout the study period. Survival by percentiles of
24hUNa: other predictors held at mean value. Joint model of longitudinal (eGFR) and survival (all-cause mortality) data (95% CI). 10th percentile
(96 mmol/24 h) is represented by – – – –; 25th percentile (128 mmol/24 h), –. – . – . –; 50th percentile (168 mmol/24 h), -.-.-.-.-.-.; 75th percentile
(216 mmol/24 h),d - -d; and 90th percentile (264 mmol/24 h), - . . - . . - . . -.
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